Mylan Plaintiffs Make New Bid For Treble Damages

Law360, New York (November 5, 2007, 12:00 AM EST) -- In its long-running antitrust litigation against Mylan Laboratories over two of the generic drug maker's anti-anxiety drugs, Blue Cross Blue Shield of Massachusetts has renewed its effort to push the court to triple damages against Mylan and two drug ingredient supplier defendants, citing details from a separate case.

In court documents filed Wednesday in the U.S. District Court for the District of Columbia, BCBS Massachusetts contends that a separate malpractice suit Mylan brought against its former antitrust counsel Eliot G. Disner, provides key information that supports...
To view the full article, register now.